Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-01-06 @ 4:02 AM
Study NCT ID:
NCT04916860
Status:
UNKNOWN
Last Update Posted:
2023-03-31
First Post:
2021-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-01
First Submit QC Date:
None
Study First Post Date:
2021-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-30
Last Update Post Date:
2023-03-31
Last Update Post Date Type:
ACTUAL